Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Beijing Municipality was added to the Locations section, replacing the former 'Beijing Municipality Locations' listing, and the page revision was updated to v3.3.3 with the HHS Vulnerability Disclosure link removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:50:32.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:13:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Notice about potential delays due to government funding has been removed; core trial details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Updates appear to be minor formatting and wording adjustments across sections. There are no changes to the study design, primary or secondary outcomes, enrollment numbers, or eligibility criteria.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:29.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about government funding impacts and NIH Clinical Center status; removed the previous v3.1.0 label.
    Difference
    3%
    Check dated 2025-10-06T05:40:47.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Update includes new revision tag v3.1.0 and new contact numbers (+86 21 20673222, +86 21 20673203), replacing the old revision tag v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-29T03:09:19.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.